Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use

Sophie I. Mavrogeni, George D. Kitas, Theodoros Dimitroulas, Petros P. Sfikakis, Philip Seo, Sherine Gabriel, Amit R. Patel, Luna Gargani, Stefano Bombardieri, Marco Matucci-Cerinic, Massimo Lombardi, Alessia Pepe, Anthony H. Aletras, Genovefa Kolovou, Tomasz Miszalski, Piet Van Riel, Annegrete Semb, Miguel Angel Gonzalez-Gay, Patrick Dessein, George KarpouzasValentina Puntman, Eike Nagel, Konstantinos Bratis, Georgia Karabela, Efthymios Stavropoulos, Gikas Katsifis, Loukia Koutsogeorgopoulou, Albert Van Rossum, Frank Rademakers, Gerald Pohost, Joao A C Lima

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

Original languageEnglish (US)
Pages (from-to)135-148
Number of pages14
JournalInternational Journal of Cardiology
Volume217
DOIs
StatePublished - Aug 15 2016

Fingerprint

Rheumatology
Magnetic Resonance Spectroscopy
Connective Tissue Diseases
Spondylarthropathies
Myositis
Sarcoidosis
Vasculitis
Cardiovascular System
Life Expectancy
Ionizing Radiation
Terminology
Systemic Lupus Erythematosus
Rheumatoid Arthritis
Coronary Vessels
Thorax
Pathology
Morbidity

Keywords

  • Cardiovascular magnetic resonance imaging
  • Rheumatic diseases

ASJC Scopus subject areas

  • Medicine(all)
  • Cardiology and Cardiovascular Medicine

Cite this

Mavrogeni, S. I., Kitas, G. D., Dimitroulas, T., Sfikakis, P. P., Seo, P., Gabriel, S., ... Lima, J. A. C. (2016). Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use. International Journal of Cardiology, 217, 135-148. https://doi.org/10.1016/j.ijcard.2016.04.158

Cardiovascular magnetic resonance in rheumatology : Current status and recommendations for use. / Mavrogeni, Sophie I.; Kitas, George D.; Dimitroulas, Theodoros; Sfikakis, Petros P.; Seo, Philip; Gabriel, Sherine; Patel, Amit R.; Gargani, Luna; Bombardieri, Stefano; Matucci-Cerinic, Marco; Lombardi, Massimo; Pepe, Alessia; Aletras, Anthony H.; Kolovou, Genovefa; Miszalski, Tomasz; Van Riel, Piet; Semb, Annegrete; Gonzalez-Gay, Miguel Angel; Dessein, Patrick; Karpouzas, George; Puntman, Valentina; Nagel, Eike; Bratis, Konstantinos; Karabela, Georgia; Stavropoulos, Efthymios; Katsifis, Gikas; Koutsogeorgopoulou, Loukia; Van Rossum, Albert; Rademakers, Frank; Pohost, Gerald; Lima, Joao A C.

In: International Journal of Cardiology, Vol. 217, 15.08.2016, p. 135-148.

Research output: Contribution to journalArticle

Mavrogeni, SI, Kitas, GD, Dimitroulas, T, Sfikakis, PP, Seo, P, Gabriel, S, Patel, AR, Gargani, L, Bombardieri, S, Matucci-Cerinic, M, Lombardi, M, Pepe, A, Aletras, AH, Kolovou, G, Miszalski, T, Van Riel, P, Semb, A, Gonzalez-Gay, MA, Dessein, P, Karpouzas, G, Puntman, V, Nagel, E, Bratis, K, Karabela, G, Stavropoulos, E, Katsifis, G, Koutsogeorgopoulou, L, Van Rossum, A, Rademakers, F, Pohost, G & Lima, JAC 2016, 'Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use', International Journal of Cardiology, vol. 217, pp. 135-148. https://doi.org/10.1016/j.ijcard.2016.04.158
Mavrogeni, Sophie I. ; Kitas, George D. ; Dimitroulas, Theodoros ; Sfikakis, Petros P. ; Seo, Philip ; Gabriel, Sherine ; Patel, Amit R. ; Gargani, Luna ; Bombardieri, Stefano ; Matucci-Cerinic, Marco ; Lombardi, Massimo ; Pepe, Alessia ; Aletras, Anthony H. ; Kolovou, Genovefa ; Miszalski, Tomasz ; Van Riel, Piet ; Semb, Annegrete ; Gonzalez-Gay, Miguel Angel ; Dessein, Patrick ; Karpouzas, George ; Puntman, Valentina ; Nagel, Eike ; Bratis, Konstantinos ; Karabela, Georgia ; Stavropoulos, Efthymios ; Katsifis, Gikas ; Koutsogeorgopoulou, Loukia ; Van Rossum, Albert ; Rademakers, Frank ; Pohost, Gerald ; Lima, Joao A C. / Cardiovascular magnetic resonance in rheumatology : Current status and recommendations for use. In: International Journal of Cardiology. 2016 ; Vol. 217. pp. 135-148.
@article{73f07c6de4544303b9771389ef2b108a,
title = "Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use",
abstract = "Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.",
keywords = "Cardiovascular magnetic resonance imaging, Rheumatic diseases",
author = "Mavrogeni, {Sophie I.} and Kitas, {George D.} and Theodoros Dimitroulas and Sfikakis, {Petros P.} and Philip Seo and Sherine Gabriel and Patel, {Amit R.} and Luna Gargani and Stefano Bombardieri and Marco Matucci-Cerinic and Massimo Lombardi and Alessia Pepe and Aletras, {Anthony H.} and Genovefa Kolovou and Tomasz Miszalski and {Van Riel}, Piet and Annegrete Semb and Gonzalez-Gay, {Miguel Angel} and Patrick Dessein and George Karpouzas and Valentina Puntman and Eike Nagel and Konstantinos Bratis and Georgia Karabela and Efthymios Stavropoulos and Gikas Katsifis and Loukia Koutsogeorgopoulou and {Van Rossum}, Albert and Frank Rademakers and Gerald Pohost and Lima, {Joao A C}",
year = "2016",
month = "8",
day = "15",
doi = "10.1016/j.ijcard.2016.04.158",
language = "English (US)",
volume = "217",
pages = "135--148",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Cardiovascular magnetic resonance in rheumatology

T2 - Current status and recommendations for use

AU - Mavrogeni, Sophie I.

AU - Kitas, George D.

AU - Dimitroulas, Theodoros

AU - Sfikakis, Petros P.

AU - Seo, Philip

AU - Gabriel, Sherine

AU - Patel, Amit R.

AU - Gargani, Luna

AU - Bombardieri, Stefano

AU - Matucci-Cerinic, Marco

AU - Lombardi, Massimo

AU - Pepe, Alessia

AU - Aletras, Anthony H.

AU - Kolovou, Genovefa

AU - Miszalski, Tomasz

AU - Van Riel, Piet

AU - Semb, Annegrete

AU - Gonzalez-Gay, Miguel Angel

AU - Dessein, Patrick

AU - Karpouzas, George

AU - Puntman, Valentina

AU - Nagel, Eike

AU - Bratis, Konstantinos

AU - Karabela, Georgia

AU - Stavropoulos, Efthymios

AU - Katsifis, Gikas

AU - Koutsogeorgopoulou, Loukia

AU - Van Rossum, Albert

AU - Rademakers, Frank

AU - Pohost, Gerald

AU - Lima, Joao A C

PY - 2016/8/15

Y1 - 2016/8/15

N2 - Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

AB - Targeted therapies in connective tissue diseases (CTDs) have led to improvements of disease-associated outcomes, but life expectancy remains lower compared to general population due to emerging co-morbidities, particularly due to excess cardiovascular risk. Cardiovascular magnetic resonance (CMR) is a noninvasive imaging technique which can provide detailed information about multiple cardiovascular pathologies without using ionizing radiation. CMR is considered the reference standard for quantitative evaluation of left and right ventricular volumes, mass and function, cardiac tissue characterization and assessment of thoracic vessels; it may also be used for the quantitative assessment of myocardial blood flow with high spatial resolution and for the evaluation of the proximal coronary arteries. These applications are of particular interest in CTDs, because of the potential of serious and variable involvement of the cardiovascular system during their course. The International Consensus Group on CMR in Rheumatology was formed in January 2012 aiming to achieve consensus among CMR and rheumatology experts in developing initial recommendations on the current state-of-the-art use of CMR in CTDs. The present report outlines the recommendations of the participating CMR and rheumatology experts with regards to: (a) indications for use of CMR in rheumatoid arthritis, the spondyloarthropathies, systemic lupus erythematosus, vasculitis of small, medium and large vessels, myositis, sarcoidosis (SRC), and scleroderma (SSc); (b) CMR protocols, terminology for reporting CMR and diagnostic CMR criteria for assessment and quantification of cardiovascular involvement in CTDs; and (c) a research agenda for the further development of this evolving field.

KW - Cardiovascular magnetic resonance imaging

KW - Rheumatic diseases

UR - http://www.scopus.com/inward/record.url?scp=84966441202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966441202&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2016.04.158

DO - 10.1016/j.ijcard.2016.04.158

M3 - Article

C2 - 27179903

AN - SCOPUS:84966441202

VL - 217

SP - 135

EP - 148

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

ER -